HCA Healthcare delivered a strong first quarter, beating expectations in both earnings and revenue.HCA Healthcare (HCA 1.64%), a prominent player in the healthcare sector, announced robust first-quarter results for 2025 on Friday, April 25, that surpassed market expectations. The company recorded an adjusted EPS of $6.45 for Q1 2025, exceeding the anticipated $5.75. Its reported revenue was $18.32 billion, slightly above the expected $18.26 billion.MetricQ1 2025Analysts' EstimateQ1 2024Change (YOY)Adjusted ...

Exhibit 99.1 For the first quarter of 2025, Adjusted EBITDA totaled $3.733 billion, compared to $3.353 billion in the first quarter of 2024. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release. Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent in the first quarter of 2025, compared ...

Group 1: Earnings Estimates - HCA Healthcare is expected to report first-quarter 2025 earnings of $5.77 per share on revenues of $18.31 billion, indicating a year-over-year earnings growth of 7.7% and revenue growth of 5.6% [1][2] - For the full year 2025, the revenue estimate is $74.69 billion, reflecting a 5.8% increase year-over-year, while the EPS estimate is $24.98, implying a 13.8% increase year-over-year [2] Group 2: Recent Performance - HCA Healthcare has consistently beaten earnings estimates in the last four quarters, with an average surprise of 5.9% [2] - The company has an Earnings ESP of 0.00% and a Zacks Rank of 3 (Hold), indicating uncertainty regarding an earnings beat for the upcoming quarter [3] Group 3: Operational Metrics - The consensus estimate for equivalent admissions shows a 3.4% year-over-year growth, while the model predicts a 3.5% increase; revenue per equivalent admission is expected to rise by 2% [5] - Equivalent patient days are estimated to grow by 1.8% year-over-year, but rising expenses and lower occupancy rates pose challenges [6] Group 4: Expense and Occupancy Trends - Total operating expenses are projected to increase by 5.8% year-over-year, driven by higher salaries, benefits, and supply costs, with supply costs expected to rise nearly 8% [7] - The occupancy rate is estimated at 72.68%, down from 75.20% a year ago, and the average length of stay is expected to decline by 2.4% [7]

Wall Street analysts expect HCA Healthcare (HCA) to post quarterly earnings of $5.77 per share in its upcoming report, which indicates a year-over-year increase of 7.7%. Revenues are expected to be $18.31 billion, up 5.6% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, ...

Core Insights - The article discusses an investment service and community focused on the oil and natural gas sector, emphasizing cash flow and the potential for value and growth in this industry [1]. Group 1: Investment Service Features - The service offers subscribers access to a model account with over 50 stocks, detailed cash flow analyses of exploration and production (E&P) firms, and live chat discussions about the sector [2]. - A promotional offer is available for a two-week free trial, encouraging new users to explore opportunities in the oil and gas market [3].

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead.If a recession does hit, it might also affect the stock market, and different companies and sectors will perform differently. Let's consider two stocks that should handle recessions better than most and are worth investing in for the long haul: Vertex Pharmaceuticals (VRTX -2.01%) and HCA Healthcare (HCA -4.78%).1. Vertex Pharmace ...

Group 1 - HCA Healthcare's shares have experienced volatility over the past year but have still achieved a 5% gain [1] - Congressional Republicans are intensifying efforts on a budget reconciliation bill aimed at tax cuts, which may impact the healthcare sector [1]

Our latest available data shows that HCA has returned about 15.1% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 3.1% on average. This means that HCA Healthcare is performing better than its sector in terms of year-to-date returns. The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has HCA Healthcare (HCA) been one of those stocks this year? A quick glance at the company's year ...

Financial Performance - Net income for HCA Healthcare, Inc. in 2024 was $5.760 billion, or $22.00 per diluted share, compared to $5.242 billion, or $18.97 per diluted share in 2023, reflecting a year-over-year increase of 9.8% in net income [314]. - Total revenues increased to $70.603 billion in 2024, up 8.7% from $64.968 billion in 2023, driven by a 5.3% increase in equivalent admissions and a 3.2% increase in revenue per equivalent admission [315]. - Revenues increased by 8.7% to $70.603 billion for 2024 from $64.968 billion for 2023, driven by a 5.3% increase in equivalent admissions and a 3.2% increase in revenue per equivalent admission [348]. - Net income attributable to HCA Healthcare, Inc. was $5.760 billion, or $22.00 per diluted share, for 2024, compared to $5.242 billion, or $18.97 per diluted share, for 2023 [371]. Admissions and Patient Volume - Consolidated admissions rose by 5.0% in 2024, with inpatient surgical volumes increasing by 2.2%, while outpatient surgical volumes declined by 1.9% [316]. - Consolidated admissions increased by 5.0% during 2024 compared to 2023, with inpatient surgical volumes increasing by 2.2% [350]. - Same facility admissions increased by 4.9% in 2024 compared to 2023 [372]. - Average daily census increased to 29,581 in 2024 from 28,721 in 2023, reflecting higher patient volume [367]. - Emergency room visits increased by 4.8% on a consolidated basis in 2024 compared to 2023, totaling 9,789,265 visits [372]. - Same facility uninsured emergency room visits increased by 13.5% during 2024 compared to 2023 [352]. Financial Expenses and Liabilities - Interest expense for 2024 totaled $2.061 billion, an increase of $123 million from $1.938 billion in 2023, primarily due to a higher average debt balance [318]. - Interest expense rose to $2.061 billion in 2024 from $1.938 billion in 2023, primarily due to an increase in average debt balance [379]. - Professional liability provisions for the current year claims were $545 million for 2024, compared to $573 million for 2023 [343]. - Reserves for professional liability risks were $2.131 billion at December 31, 2024, compared to $2.089 billion at December 31, 2023, with a current portion of $587 million [342]. - The estimated total net reserves for professional liability risks at December 31, 2024, included $1.059 billion for case reserves for known claims and $992 million for reserves for incurred but not reported claims [342]. Operating Activities and Cash Flow - Cash flows from operating activities increased by $1.083 billion to $10.514 billion in 2024, attributed to a $542 million increase in net income and a positive change in working capital items [319]. - Cash provided by operating activities totaled $10.514 billion in 2024, an increase of $1.083 billion compared to $9.431 billion in 2023 [384]. - Cash used in investing activities was $4.933 billion in 2024, compared to $5.317 billion in 2023 [385]. - Cash used in financing activities totaled $4.582 billion in 2024, up from $4.094 billion in 2023 [388]. Strategic Initiatives - HCA Healthcare plans to expand its presence in existing markets by developing outpatient facilities and comprehensive service lines, including cardiology and oncology [320]. - The company aims to achieve industry-leading performance in clinical and operational measures through initiatives focused on patient safety and satisfaction [322]. - HCA Healthcare emphasizes recruiting and retaining healthcare professionals to ensure high-quality services, supported by advanced technology and expanded specialty services [323]. - The company intends to pursue a disciplined development strategy, focusing on selectively developing and acquiring new hospitals and outpatient facilities to capitalize on growth opportunities [325]. Cost and Revenue Ratios - The cost-to-charges ratio for patient care costs was 10.1% for 2024, down from 10.5% in 2023 [334]. - Salaries and benefits as a percentage of revenues decreased to 44.1% in 2024 from 45.4% in 2023 [374]. - Other operating expenses increased to 21.0% of revenues in 2024 from 19.8% in 2023, primarily due to increased costs for state provider fees and repairs related to Hurricane Milton [376]. Long-term Debt and Tax Matters - Total long-term debt was $43.031 billion at December 31, 2024, compared to $39.593 billion at December 31, 2023 [394]. - The estimated fair value of total long-term debt was $40.845 billion at December 31, 2024 [406]. - The average effective interest rate for long-term debt remained at 5.0% for both 2024 and 2023 [379]. - The IRS completed examinations of the company's 2016, 2017, and 2018 income tax returns, resolving all federal income tax matters for those years [408]. - As of December 31, 2024, the IRS is examining the company's 2022 and 2023 income tax returns, along with the 2019 returns of certain affiliates [408]. - The company believes it has properly reported taxable income and paid taxes in accordance with applicable laws, minimizing potential adverse effects on financial position [408]. - Future tax resolutions could materially impact the company's results if payments exceed recorded estimates [408].

Group 1: Market Overview - Equity markets have experienced volatility due to competition from Chinese companies in the AI sector, which significantly impacts indexes like the Nasdaq Composite [1] - The Trump administration's potential tariffs on various countries may lead to retaliatory actions, further affecting stock market performance [1] Group 2: Johnson & Johnson - Johnson & Johnson operates in the defensive healthcare industry, which remains stable during market downturns as demand for medical services persists [3] - The company is a pharmaceutical leader with a diverse portfolio, including drugs that generate over $1 billion in annual sales across various therapeutic areas [4] - Johnson & Johnson's medical devices segment also contributes to its stability, providing essential services that are less affected by economic fluctuations [5] - The company has a strong track record of revenue and earnings growth, supported by its ability to innovate in medicines and medical devices [6] - Johnson & Johnson is nearing a settlement for over 99.75% of lawsuits related to its talc-based products, which may alleviate some legal pressures [6] - The company has consistently delivered strong financial results and has a history of increasing dividends for 62 consecutive years, making it a reliable investment during downturns [8] Group 3: HCA Healthcare - HCA Healthcare is a leading hospital chain in the U.S., with a significant presence in Texas and Florida, and its services remain in demand during economic downturns [9] - While elective surgeries may decline during recessions, the overall need for hospital services remains high, ensuring steady demand for HCA Healthcare [10] - The company has successfully increased its market share from 26.5% in 2019 to approximately 28% in 2021, demonstrating resilience during challenging times [10] - HCA Healthcare benefits from established relationships with third-party payers, patients, and physicians, providing a competitive advantage in the industry [12] - Projections indicate that hospital spending will continue to rise, positioning HCA Healthcare to capitalize on this long-term trend and deliver strong returns for investors [13]